D.E. Shaw & Co’s AEON Biopharma, Inc. Warrants, each whole warrant exercisable to purchase one share of Class A Common Stock at an exercise price of $11.50 per share AEON.WS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-154,432
| Closed | -$224K | – | 3570 |
|
|
2024
Q1 | $224K | Hold |
154,432
| – | – | ﹤0.01% | 2721 |
|
|
2023
Q4 | $15.4K | Hold |
154,432
| – | – | ﹤0.01% | 2877 |
|
|
2023
Q3 | $23.2K | Buy |
154,432
+121,099
| +363% | +$18.2K | ﹤0.01% | 2790 |
|
|
2023
Q2 | $3K | Hold |
33,333
| – | – | ﹤0.01% | 3008 |
|
|
2023
Q1 | $2K | Hold |
33,333
| – | – | ﹤0.01% | 3256 |
|
|
2022
Q4 | $1.52K | Hold |
33,333
| – | – | ﹤0.01% | 3532 |
|
|
2022
Q3 | $2K | Hold |
33,333
| – | – | ﹤0.01% | 3813 |
|
|
2022
Q2 | $5K | Hold |
33,333
| – | – | ﹤0.01% | 4051 |
|
|
2022
Q1 | $10K | Hold |
33,333
| – | – | ﹤0.01% | 4156 |
|
|
2021
Q4 | $17K | Hold |
33,333
| – | – | ﹤0.01% | 3896 |
|
|
2021
Q3 | $18K | Hold |
33,333
| – | – | ﹤0.01% | 3574 |
|
|
2021
Q2 | $34K | Buy |
+33,333
| New | +$34K | ﹤0.01% | 3444 |
|